Article
Precision Medicine: IL-1RA and Pancreatic Cancer Organoids
25 May 2025
Abstract excerpt
Cancer organoids have emerged as transformative models for studying tumor biology and therapeutic responses due to the ability to replicate the complexity of the tumor microenvironment (TME). Tumor organoids recapitulate the genetic and phenotypic diversity of cancers, making them invaluable for investigating mechanisms of resistance and identifying novel therapeutic targets. Patient-derived organoids (PDOs)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
